Blaise G A, Stewart D J, Guérard M J
Department of Anesthesiology, Hôpital Notre-Dame, Université de Montréal, Quebec.
Can J Cardiol. 1993 Nov;9(9):813-20.
To determine whether cholinergic stimulation of human coronary endothelial cells induces the release of endothelium-derived relaxing factor (EDRF), denuded human coronary artery rings or denuded rabbit aorta rings were either directly perfused or superfused by the effluent of intact or denuded human coronary artery segments in a perfusion bioassay system.
Coronary vessels were dissected from hearts of organ donors and prepared for use as donor segments and detector rings in the perfusion bioassay system. Segments were continuously perfused by an oxygenated Krebs-Ringer solution. Rings were suspended between two stirrups, one of which was connected to an isometric force transducer. They were either directly perfused (no tissue had been previously perfused by the same Krebs-Ringer) or superfused by the effluent of an endothelium-intact or -denuded coronary segment. Human rings were contracted with prostaglandin F2 alpha (2 x 10(-6) M) and rabbit rings were contracted with phenylephrine (10(-6) M).
Tension in detector tissue did not change during superfusion with effluent from endothelium-denuded or -intact human coronary artery segments, showing that there was no basal release of EDRF/nitric oxide (NO) in this preparation. Acetylcholine (ACh) (10(-6) or 10(-5) M) added to the perfusate increased the tension of the precontracted endothelium-denuded human rings directly perfused (50 +/- 32%) but not of the precontracted rabbit rings, showing that ACh is a potent agonist of human coronary vascular smooth muscle. ACh added to the coronary segment in the endothelium-intact superfusion mode had no effect in 33% or induced a small relaxation (8.8 +/- 1.6%) in 66% of the preparations. Hemoglobin (10(-5) M), a scavenger of EDRF/NO, caused a further increase in tension (32 +/- 15%). Adding calcium ionophore (A 23187;10(-5) M), which stimulates EDRF/NO release through a nonreceptor-mediated mechanism, to the coronary artery segment induced a relaxation in the endothelium-perfused detector rings which did not relax to ACh (30 +/- 2%); this relaxation was reversed by methylene blue (10(-5) M), a blocker of soluble guanylate cyclase. NO endothelin, a potent vasoconstrictor released by the endothelial cells, was detected in the effluent of intact coronary vessels.
The results suggest that in two-thirds of the six preparations studied, cholinergic stimulation can release EDRF from human donor coronary artery endothelial cells.
为了确定对人冠状动脉内皮细胞的胆碱能刺激是否会诱导内皮源性舒张因子(EDRF)的释放,在灌注生物测定系统中,对去内皮的人冠状动脉环或去内皮的兔主动脉环直接进行灌注,或用完整或去内皮的人冠状动脉段的流出液进行灌流。
从器官捐献者的心脏中解剖出冠状动脉血管,制备成供体段和检测环,用于灌注生物测定系统。供体段用含氧的 Krebs-Ringer 溶液持续灌注。检测环悬挂在两个马镫之间,其中一个与等长力传感器相连。它们要么直接灌注(之前没有用相同的 Krebs-Ringer 溶液灌注过组织),要么用内皮完整或去内皮的冠状动脉段的流出液进行灌流。人冠状动脉环用前列腺素 F2α(2×10⁻⁶ M)收缩,兔主动脉环用去氧肾上腺素(10⁻⁶ M)收缩。
在用去内皮或内皮完整的人冠状动脉段的流出液进行灌流期间,检测组织中的张力没有变化,表明在该制备中没有 EDRF/一氧化氮(NO)的基础释放。添加到灌注液中的乙酰胆碱(ACh)(10⁻⁶ 或 10⁻⁵ M)增加了直接灌注的预先收缩的去内皮人冠状动脉环的张力(50±32%),但没有增加预先收缩的兔主动脉环的张力,表明 ACh 是人类冠状动脉血管平滑肌的强效激动剂。在内皮完整的灌流模式下添加到冠状动脉段的 ACh 在 33%的制剂中没有作用,或在 66%的制剂中诱导了小幅度的舒张(8.8±1.6%)。血红蛋白(10⁻⁵ M),一种 EDRF/NO 的清除剂,导致张力进一步增加(32±15%)。向冠状动脉段添加钙离子载体(A 23187;10⁻⁵ M),其通过非受体介导的机制刺激 EDRF/NO 的释放,可诱导内皮灌流的检测环舒张,而这些环对 ACh 不舒张(30±2%);这种舒张被亚甲蓝(10⁻⁵ M)逆转,亚甲蓝是可溶性鸟苷酸环化酶的阻滞剂。在完整冠状动脉血管的流出液中检测到内皮素,一种由内皮细胞释放的强效血管收缩剂。
结果表明,在所研究的六个制剂中的三分之二,胆碱能刺激可使人供体冠状动脉内皮细胞释放 EDRF。